IN2013MU00957A - - Google Patents

Download PDF

Info

Publication number
IN2013MU00957A
IN2013MU00957A IN957MU2013A IN2013MU00957A IN 2013MU00957 A IN2013MU00957 A IN 2013MU00957A IN 957MU2013 A IN957MU2013 A IN 957MU2013A IN 2013MU00957 A IN2013MU00957 A IN 2013MU00957A
Authority
IN
India
Prior art keywords
therapeutic agents
nanohybrid
nanovesicles
nanoparticles
delivery
Prior art date
Application number
Other languages
English (en)
Inventor
Banerjee Prof Rinti
Kaur Shahdeep
Original Assignee
Indian Inst Technology Bombay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indian Inst Technology Bombay filed Critical Indian Inst Technology Bombay
Priority to IN957MU2013 priority Critical patent/IN2013MU00957A/en
Publication of IN2013MU00957A publication Critical patent/IN2013MU00957A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
IN957MU2013 2013-03-21 2013-03-21 IN2013MU00957A (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN957MU2013 IN2013MU00957A (https=) 2013-03-21 2013-03-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN957MU2013 IN2013MU00957A (https=) 2013-03-21 2013-03-21

Publications (1)

Publication Number Publication Date
IN2013MU00957A true IN2013MU00957A (https=) 2015-05-29

Family

ID=54395072

Family Applications (1)

Application Number Title Priority Date Filing Date
IN957MU2013 IN2013MU00957A (https=) 2013-03-21 2013-03-21

Country Status (1)

Country Link
IN (1) IN2013MU00957A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118924703A (zh) * 2024-07-24 2024-11-12 中山大学 负载水溶性药物的脂质纳米粒体系及其制备方法和应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118924703A (zh) * 2024-07-24 2024-11-12 中山大学 负载水溶性药物的脂质纳米粒体系及其制备方法和应用

Similar Documents

Publication Publication Date Title
WO2015009726A3 (en) Medical uses of cd38 agonists
MY180365A (en) Markers of tumor cell response to anti-cancer therapy
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
MX389254B (es) Antagonistas de activina-actrii y usos para tratar trastornos oseos y otros.
MX363243B (es) Composiciones para tratar cáncer y usos de dichas composiciones.
PH12015502042A1 (en) Use of linagliptin in cardio-and renoprotective antidiabetic therapy
WO2016025635A3 (en) Combination therapy for treating cancer
MX375442B (es) Un agente terapéutico y un agente mejorador de la permeación intracelular para usarse en el tratamiento de cáncer.
SG10201902664RA (en) Combination therapy for treating cancer
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
PH12016500164B1 (en) Therapeutically active compounds and their methods of use
WO2014145642A3 (en) Nrf2 small molecule inhibitors for cancer therapy
NZ719049A (en) Cancer treatment with combination of plinabulin and taxane
CA2908742C (en) Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer
IL234701B (en) Topically administered strontium-containing complexes for treating pain, pruritis and inflammation
WO2015095834A3 (en) Cancer treatments using erk1/2 and bcl-2 family inhibitors
WO2016043874A3 (en) Combination therapy for treating cancer
IN2014MN01945A (https=)
EP3318879A4 (en) Gpc3-targeted therapeutic agent administered to patient in whom gpc3-targetd therapeutic ag
IL254228A0 (en) Cell therapy agent for cancer treatment and combined therapy with it
MX2018010223A (es) Terapia combinada para tratamiento de cancer de ovario.
MX2013008175A (es) Composiciones farmacéuticas para suministro tópico de fotosensibilizadores y usos de los mismos.
IN2014MN01944A (https=)
MX2018006776A (es) Usos de pirimido-piridazinonas para tratar el cancer.
WO2015063613A3 (en) Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents